Period:
Draw Mode:
| Volume | 9,450 |
|
|||||
| News | - | ||||||
| Day High | 7.3299 | Low High |
|||||
| Day Low | 6.60 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CollPlant Biotechnologies Ltd | CLGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.2099 | 3.11% | 6.95 | 14:14:31 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.60 | 6.60 | 7.3299 | 6.7401 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 61 | 9,450 | $ 7.11 | $ 67,237 | - | 4.27 - 13.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:11:53 | 190 | $ 6.95 | USD |
CollPlant Biotechnologies Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 68.91M | 9.91M | 9.91M | $ 15.64M | $ 181.44k | -0.87 | 62.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
CollPlant Biotechnologies News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.89 | 8.4119 | 6.50 | 7.24 | 7,996 | -0.94 | -11.91% |
| 1 Month | 10.00 | 10.9794 | 6.50 | 8.64 | 9,794 | -3.05 | -30.5% |
| 3 Months | 9.45 | 13.97 | 6.50 | 10.12 | 15,917 | -2.50 | -26.46% |
| 6 Months | 6.76 | 13.97 | 4.27 | 8.35 | 21,580 | 0.19 | 2.81% |
| 1 Year | 11.92 | 13.97 | 4.27 | 8.42 | 21,013 | -4.97 | -41.69% |
| 3 Years | 8.55 | 24.26 | 4.27 | 13.92 | 37,866 | -1.60 | -18.71% |
| 5 Years | 7.50 | 24.26 | 3.13 | 12.84 | 28,675 | -0.55 | -7.33% |
CollPlant Biotechnologies Description
| CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. |